← All organizations

Replimune Inc.

For profitWebsite ↗

Also known as: Replimune Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 8, 2025

Timeline

2010s

Mar 1, 2015
Replimune Inc.— Founded

Drugs by trial phase (17 distinct, 16 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 2 (11 own, 0 via acquisition)

Indications

Studied for

Recent trials (26)

NCT06590480Lead sponsorN/A—
NCT06590480OfficialN/A—
NCT07059611CollaboratorPhase 2Nov 8, 2025
NCT06898970CollaboratorPhase 2Oct 31, 2025
NCT06623110CollaboratorPhase 2Mar 31, 2025
NCT06581406Lead sponsorPhase 2/Phase 3Jan 27, 2025
NCT06581406OfficialPhase 2/Phase 3Jan 27, 2025
NCT06264180OfficialPhase 3Jul 11, 2024
NCT06264180Lead sponsorPhase 3Jul 11, 2024
NCT05733598Lead sponsorPhase 2Apr 1, 2024
NCT05733598Study chairPhase 2Apr 1, 2024
NCT06216938CollaboratorEarly Phase 1Feb 2, 2024
NCT05743270Study directorPhase 2Jan 30, 2024
NCT05743270OfficialPhase 2Jan 30, 2024
NCT05743270Lead sponsorPhase 2Jan 30, 2024

Details

Founded: Woburn, MA, US Mar 1, 2015
Last known activity: Nov 8, 2025